Item Type | Name |
Concept
|
Histocytochemistry
|
Concept
|
Immunohistochemistry
|
Concept
|
Molecular Biology
|
Concept
|
Fatal Outcome
|
Concept
|
Caveolin 1
|
Academic Article
|
Quality of care in inflammatory bowel disease: a review and discussion.
|
Academic Article
|
The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey.
|
Academic Article
|
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.
|
Academic Article
|
The peri-appendiceal red patch in ulcerative colitis: review of the University of Chicago experience.
|
Academic Article
|
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
|
Academic Article
|
Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data.
|
Academic Article
|
Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
|
Academic Article
|
Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: results from the CHARM trial.
|
Academic Article
|
Infectious proctitis: when to suspect it is not inflammatory bowel disease.
|
Academic Article
|
Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction.
|
Academic Article
|
Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease.
|
Academic Article
|
Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study.
|
Academic Article
|
miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes.
|
Academic Article
|
When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations.
|
Academic Article
|
Active Crohn's disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging.
|
Academic Article
|
A practical, evidence-based guide to the use of adalimumab in Crohn's disease.
|
Academic Article
|
Total abdominal colectomy for refractory ulcerative colitis. Surgical treatment in evolution.
|
Academic Article
|
Clinical scenarios in IBD: optimizing the use of conventional and biologic agents.
|
Academic Article
|
We once were blind and now we see: is it time to treat ulcerative colitis to achieve mucosal healing?
|
Academic Article
|
Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.
|
Academic Article
|
In memoriam: Dr Joseph Barnett Kirsner.
|
Academic Article
|
Joseph Barnett Kirsner, MD, PhD.
|
Academic Article
|
Rifaximin Is Effective for the Treatment of Clostridium difficile-Associated Diarrhea: Results of an Open-Label Pilot Study.
|
Academic Article
|
Joseph Barnett Kirsner, MD, PhD.
|
Academic Article
|
Novel diagnostic and prognostic modalities in inflammatory bowel disease.
|
Academic Article
|
Performance of CT colonography in clinical trials.
|
Academic Article
|
Assessment of variables associated with smoking cessation in Crohn's disease.
|
Academic Article
|
Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis.
|
Academic Article
|
In memoriam.
|
Academic Article
|
Quality indicators for inflammatory bowel disease: development of process and outcome measures.
|
Academic Article
|
Dynamic neural networks supporting memory retrieval.
|
Academic Article
|
A diagnosis that eats at you.
|
Academic Article
|
Serum adalimumab concentration and clinical remission in patients with Crohn's disease.
|
Academic Article
|
Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
|
Academic Article
|
Summaries for patients. Increased risk for gastrointestinal cancer in childhood cancer survivors.
|
Academic Article
|
Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy.
|
Academic Article
|
Screening for sleep disorders in pediatric primary care: are we there yet?
|
Academic Article
|
Colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection in a child.
|
Academic Article
|
Joseph Barnett Kirsner, MD, PhD.
|
Academic Article
|
Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center.
|
Academic Article
|
Patient perceptions of fecal microbiota transplantation for ulcerative colitis.
|
Academic Article
|
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.
|
Academic Article
|
What you see is not always what you get: raising the bar on clinical trial methodology in ulcerative colitis.
|
Academic Article
|
Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease.
|
Academic Article
|
A rapid and accurate method to detect active small bowel gastrointestinal bleeding on video capsule endoscopy.
|
Academic Article
|
Chronic pouchitis versus recurrent Crohn's disease: a diagnostic challenge.
|
Academic Article
|
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.
|
Academic Article
|
Describing the clinical phenotypes of Crohn's disease: lessons from the past: commentary on: the broadening conception of regional ileitis.
|
Academic Article
|
Fecal microbiota transplantation: an interest in IBD?
|
Academic Article
|
Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease.
|
Academic Article
|
Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.
|
Academic Article
|
Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's disease.
|
Academic Article
|
Patchy colitis and interstitial lung disease.
|
Academic Article
|
Why it's time for updated U.S. colorectal cancer prevention guidelines in inflammatory bowel disease.
|
Academic Article
|
Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.
|
Academic Article
|
Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel disease.
|
Academic Article
|
Initial experience of a through-the-scope balloon device for ileal intubation in Crohn's disease.
|
Academic Article
|
Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients.
|
Academic Article
|
The rationale and growth of advanced training in inflammatory bowel disease.
|
Academic Article
|
Can we improve on the "see one, do one, teach one" paradigm in training fellows to care for patients with inflammatory bowel disease?
|
Academic Article
|
Curbing our enthusiasm for fecal transplantation in ulcerative colitis.
|
Academic Article
|
Introduction to the 80th anniversary issue of Digestive Diseases and Sciences.
|
Academic Article
|
Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital.
|
Academic Article
|
Ethical considerations for clinical trials in inflammatory bowel disease.
|
Academic Article
|
Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation.
|
Academic Article
|
Subdural hemorrhage in pediatric patients with enlargement of the subarachnoid spaces.
|
Academic Article
|
Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.
|
Academic Article
|
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.
|
Academic Article
|
Hematochezia and a Mesenteric Mass.
|
Academic Article
|
Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases.
|
Academic Article
|
Use of Serum Infliximab Level Prior to Cyclosporine Salvage Therapy in Severe Ulcerative Colitis.
|
Academic Article
|
Assessment of Tandem Measurements of pH and Total Gut Transit Time in Healthy Volunteers.
|
Academic Article
|
Successful Treatment of Ulcerative Colitis With Vedolizumab in a Patient With an Infliximab-Associated Psoriasiform Rash.
|
Academic Article
|
U.S. Patients with Ulcerative Colitis Do Not Have a Decreased Risk of Diverticulosis.
|
Academic Article
|
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
|
Academic Article
|
Using a Treat-to-Target Management Strategy to Improve the Doctor-Patient Relationship in Inflammatory Bowel Disease.
|
Academic Article
|
Penetrating Disease, Narcotic Use, and Loop Ostomy Are Associated with Ostomy and IBD-related Complications After Ostomy Surgery in Crohn's Disease Patients.
|
Academic Article
|
Deep enteroscopy with a conventional colonoscope: initial multicenter study by using a through-the-scope balloon catheter system.
|
Academic Article
|
Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy.
|
Academic Article
|
Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis.
|
Academic Article
|
Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice.
|
Academic Article
|
Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn's Disease in the United States.
|
Academic Article
|
Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia.
|
Academic Article
|
Vedolizumab in the treatment of Crohn's disease.
|
Academic Article
|
Patients with Ulcerative Colitis Are More Concerned About Complications of Their Disease than Side Effects of Medications.
|
Academic Article
|
Clostridium Difficile Infection in Ulcerative Colitis: Can Alteration of the Gut-associated Microbiome Contribute to Pouch Failure?
|
Academic Article
|
Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.
|
Academic Article
|
When Should Therapy for Inflammatory Bowel Disease Be Stopped?
|
Academic Article
|
Safety and Efficacy of Live Measles Vaccine Administered to a Crohn's Disease Patient Receiving Vedolizumab.
|
Academic Article
|
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel.
|
Academic Article
|
Insights into the pathogenesis of ulcerative colitis from a murine model of stasis-induced dysbiosis, colonic metaplasia, and genetic susceptibility.
|
Academic Article
|
Activation of the Renin-Angiotensin System Promotes Colitis Development.
|
Academic Article
|
Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease.
|
Academic Article
|
Current approaches for optimizing the benefit of biologic therapy in ulcerative colitis.
|
Academic Article
|
Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis.
|
Academic Article
|
Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies.
|
Academic Article
|
Histological inflammation increases the risk of colorectal neoplasia in ulcerative colitis: a systematic review.
|
Academic Article
|
Home Sweet Home? Will Medical Homes Be Coming to Your Neighborhood Sometime Soon?
|
Academic Article
|
Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.
|
Academic Article
|
Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial.
|
Academic Article
|
Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease.
|
Academic Article
|
A Review of Inflammatory Bowel Disease in the Setting of Liver Transplantation.
|
Academic Article
|
Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis.
|
Academic Article
|
Long-term Efficacy of Vedolizumab for Ulcerative Colitis.
|
Academic Article
|
Long-term Efficacy of Vedolizumab for Crohn's Disease.
|
Academic Article
|
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.
|
Academic Article
|
Primary Rosai-Dorfman disease of the femur.
|
Academic Article
|
Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin.
|
Academic Article
|
Outcomes of colitis-associated dysplasia after referral from the community to a tertiary center.
|
Academic Article
|
Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease.
|
Academic Article
|
When Subjects Violate the Research Covenant: Lessons Learned from a Failed Clinical Trial of Fecal Microbiota Transplantation.
|
Academic Article
|
Patient-Specific Bacteroides Genome Variants in Pouchitis.
|
Academic Article
|
The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access.
|
Academic Article
|
Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
|
Academic Article
|
The Role of Biosimilars in Inflammatory Bowel Disease.
|
Academic Article
|
Assessment of corticosteroid-related quality of care measures for ulcerative colitis and Crohn's disease in the United States: a claims data analysis.
|
Academic Article
|
Detection of adalimumab and antibodies to adalimumab using a homogeneous mobility shift assay.
|
Academic Article
|
Two Complex Cases of Hermansky-Pudlak Syndrome Highlight a Potential Biologic Explanation for an Associated Crohn's Disease Phenotype.
|
Academic Article
|
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists.
|
Academic Article
|
The Rationale and Growth of Advanced Training in Inflammatory Bowel Disease.
|
Academic Article
|
The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions.
|
Academic Article
|
Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
|
Academic Article
|
Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
|
Academic Article
|
Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
|
Academic Article
|
Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient-Physician Visits.
|
Academic Article
|
Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.
|
Academic Article
|
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
|
Academic Article
|
Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States.
|
Academic Article
|
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
|
Academic Article
|
miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD.
|
Academic Article
|
miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.
|
Academic Article
|
Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.
|
Academic Article
|
Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon.
|
Academic Article
|
Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety.
|
Academic Article
|
Legal Risks and Considerations Associated with Inflammatory Bowel Disease: A Primer.
|
Academic Article
|
Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial.
|
Academic Article
|
Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease.
|
Academic Article
|
Methotrexate for the Treatment of Pediatric Crohn's Disease: A Systematic Review and Meta-analysis.
|
Academic Article
|
Rapid Onset of Inflammatory Bowel Disease after Receiving Secukinumab Infusion.
|
Academic Article
|
Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies.
|
Academic Article
|
Emerging Therapies for Inflammatory Bowel Disease.
|
Academic Article
|
Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.
|
Academic Article
|
Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics.
|
Academic Article
|
Response.
|
Academic Article
|
Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies.
|
Academic Article
|
Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
|
Academic Article
|
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease.
|
Academic Article
|
A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn's disease.
|
Academic Article
|
Burden of Ulcerative Colitis on Functioning and Well-being: A Systematic Literature Review of the SF-36® Health Survey.
|
Academic Article
|
Utility of video capsule endoscopy for longitudinal monitoring of Crohn's disease activity in the small bowel: a prospective study.
|
Academic Article
|
Discussion of Code Status in the Peri-Endoscopic Period.
|
Academic Article
|
The Influence of Physician Payments on the Method of Breast Reconstruction: A National Claims Analysis.
|
Academic Article
|
The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information.
|
Academic Article
|
The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
|
Academic Article
|
Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational Studies.
|
Academic Article
|
Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
|
Academic Article
|
Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials.
|
Academic Article
|
Enteric infections complicating ulcerative colitis.
|
Academic Article
|
Effects of non-medical switching on outcomes among patients prescribed tumor necrosis factor inhibitors.
|
Academic Article
|
Meet the Master: Joseph Barnett Kirsner (1909-2012).
|
Academic Article
|
Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab.
|
Academic Article
|
Correction to: Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
|
Academic Article
|
The Drivers of Discretionary Utilization: Clinical History Versus Physician Supply.
|
Academic Article
|
Increased mucosal expression of miR-215 precedes the development of neoplasia in patients with long-standing ulcerative colitis.
|
Academic Article
|
Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease.
|
Academic Article
|
Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases.
|
Academic Article
|
Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
|
Academic Article
|
Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2.
|
Academic Article
|
Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease.
|
Academic Article
|
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease.
|
Academic Article
|
The use of tofacitinib in the treatment of inflammatory bowel disease.
|
Academic Article
|
The New Frontier: the Intestinal Microbiome and Surgery.
|
Academic Article
|
Recent Research on Joint Pain and Arthritis in Patients With Inflammatory Bowel Disease.
|
Academic Article
|
Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
|
Academic Article
|
Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia.
|
Academic Article
|
Real-World Experience with Tofacitinib in IBD at a Tertiary Center.
|
Academic Article
|
Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.
|
Academic Article
|
IBD-associated Colon Cancers Differ in DNA Methylation and Gene Expression Profiles Compared With Sporadic Colon Cancers.
|
Academic Article
|
Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.
|
Academic Article
|
Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply.
|
Academic Article
|
Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysis.
|
Academic Article
|
Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial.
|
Academic Article
|
Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease.
|
Academic Article
|
Abnormal Pouchogram Predicts Pouch Failure Even in Asymptomatic Patients.
|
Academic Article
|
Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn's Disease After Ileal Resection: A Retrospective Cohort Study.
|
Academic Article
|
ACG Clinical Guideline: Ulcerative Colitis in Adults.
|
Academic Article
|
Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease.
|
Academic Article
|
Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases.
|
Academic Article
|
Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.
|
Academic Article
|
Renin-angiotensin system promotes colonic inflammation by inducing TH17 activation via JAK2/STAT pathway.
|
Academic Article
|
Histologic Remission in Ulcerative Colitis: Are We There Yet?
|
Academic Article
|
Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.
|
Academic Article
|
Challenges in IBD Research: Pragmatic Clinical Research.
|
Academic Article
|
The Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know?
|
Academic Article
|
Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending.
|
Academic Article
|
Proposal to Update the Curriculum in Inflammatory Bowel Diseases for Categorical Gastroenterology Fellows.
|
Academic Article
|
Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission.
|
Academic Article
|
Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis.
|
Academic Article
|
Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development.
|
Academic Article
|
Patient and physician preferences for ulcerative colitis treatments in the United States.
|
Academic Article
|
Treatment De-Escalation in Patients With Inflammatory Bowel Disease.
|
Academic Article
|
Clinical Approach to Lactose Intolerance.
|
Academic Article
|
Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population.
|
Academic Article
|
Exposure to Anti-tumor Necrosis Factor Medications Increases the Incidence of Pouchitis After Restorative Proctocolectomy in Patients With Ulcerative Colitis.
|
Academic Article
|
New Diagnosis of Acquired Immunodeficiency Syndrome in a Patient With Crohn's Disease.
|
Academic Article
|
Vacant Properties and Violence in Neighborhoods.
|
Academic Article
|
Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
|
Academic Article
|
Use of Tofacitinib for the Treatment of Arthritis Associated With Ulcerative Colitis.
|
Academic Article
|
Restarting Biologic Agents After a Drug Holiday.
|
Academic Article
|
Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting.
|
Academic Article
|
[Nephrotic syndrome and microhematuria in a patient with nutcracker syndrome: Report of a case and review of the literature].
|
Academic Article
|
Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic.
|
Academic Article
|
Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic.
|
Academic Article
|
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
|
Academic Article
|
Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis.
|